Skip to main content

Peer Review reports

From: Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

Original Submission
6 Dec 2012 Submitted Original manuscript
21 Dec 2012 Author responded Author comments - Igor Bondarenko
Resubmission - Version 2
21 Dec 2012 Submitted Manuscript version 2
25 Jan 2013 Author responded Author comments - Igor Bondarenko
Resubmission - Version 3
25 Jan 2013 Submitted Manuscript version 3
5 Mar 2013 Reviewed Reviewer Report - Caterina Fontanella
22 Apr 2013 Reviewed Reviewer Report - Jean Klastersky
24 May 2013 Author responded Author comments - Igor Bondarenko
Resubmission - Version 4
24 May 2013 Submitted Manuscript version 4
Publishing
21 Jun 2013 Editorially accepted
14 Aug 2013 Article published 10.1186/1471-2407-13-386

You can find further information about peer review here.

Back to article page